Evaluation of the safety and efficacy of recombinant Factor IX (nonacog alfa) in Japanese patients with hemophilia B - The second interim analysis of 304 patients in a post-marketing surveillance study
HAEMOPHILIA(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要